Allison Schneider, MPH, provides expertise on how IRA drug price negotiations have impacted pharmacies in 2026 and what’s to come in the years ahead.
Allison Schneider, MPH
Advertisement
Allison Schneider, MPH, director at ADVI Health
Articles by Allison Schneider, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
CagriSema Reduces Weight in Women Across Menopause Stages, HT Use
2
EloraTZP Shows Greater Weight Loss, A1C Reduction Than Tirzepatide
3
Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use
4
White House Declares Increased Focus on Women’s Health in US
5